ALBUQUERQUE, NM and TEL AVIV, Israel – May 20, 2021 – Indica Labs, an industry leader in quantitative digital pathology & image management solutions, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, announced an agreement to integrate the Galen™ AI-based cancer diagnostics platform into the HALO AP® digital pathology workflow platform.
Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue growth rate for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase year-over-year, reinforcing its position as a market leader in digital pathology diagnostics.
Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets Read More »
With deep expertise in custom integration and database migration, we unify diverse data streams into interoperable workflows and reliably transition legacy image management systems (IMS) to the HALO Link and HALO AP® enterprise pathology platforms.
Integration and Migration Services Read More »
HALO AP seamlessly integrates with a wide selection of AI and image analysis innovations, LIS | LIMS, and diverse software platforms, offering unparalleled flexibility for your clinical workflow.
Integrating Innovation: HALO AP® as an AI Orchestration Platform for Digital Pathology Read More »
At Indica Labs, we’ve built aa ecosystem of partnerships to promote open pathology and interoperability, enabling our customers to choose best-of-breed products across integrated digital pathology workflows.
HALO AP is an AI-powered, pathologist-driven diagnostic pathology platform that brings together patient data, whole slide images, and AI-based decision support tools to enable remote working, primary diagnosis, and other routine workflows in anatomic pathology.
From discovery to diagnostics, AI powers our entire HALO software suite and services. Advance your pathology research with our AI-powered image analysis and collaborative image management platforms.
AI-Powered Pathology Read More »
As 2021 draws to a close, the team at Indica Labs would like to take this opportunity to reflect on the year and to thank our customers for their continued support through this second pandemic year. Despite the ongoing challenges that the pandemic presents, we celebrate the achievements of our customers who have published over 250 publications in peer-reviewed journals this year with an impressive average impact factor of 9.12. To learn more about these publications spanning immuno-oncology, oncology, immunology, infectious disease, and neurology, read our high-impact publications guide and visit our Literature page.
2021: A Year in Review at Indica Labs Read More »
